Corvus Pharmaceuticals
CRVS
CRVS
57 hedge funds and large institutions have $279M invested in Corvus Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 29 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less capital invested
Capital invested by funds: $288M → $279M (-$9.17M)
Holders
57
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.2M | |
| 2 | +$892K | |
| 3 | +$770K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$673K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$586K |
Top Sellers
| 1 | -$2.85M | |
| 2 | -$1.14M | |
| 3 | -$1.12M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$890K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$811K |